Anbio Biotechnology Surges 4.47% Amid Volatile Market – Is It a Buying Opportunity?
Anbio Biotechnology shares rise 4.47% amid volatile biotech market, trading near 52‑week lows—possible entry point for cautious investors.
- ANBIO BIOTECHNOLOGY LTD
- Germany
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read